What is NRX Pharmaceuticals Inc?
, a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder (PTSD), and schizophrenia in the United States.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder (PTSD), and schizophrenia in the United States. It operates through NRx and Dura segments. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 95.59M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.